Jennifer Lew

Jennifer Lew is a declared insider at 2 companies (finance chief); the most frequent names are Chinook Therapeutics, Inc. and Annexon, Inc. We count 49 filings; the first trade dates from 6 January 2016 and the latest from 2 March 2026.

On the open market, the record shows 1 purchase worth €29k and 25 sales worth €878k. Sales outweigh purchases by €849k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 8 share grants and 15 option exercises. In 2026 alone, the filings show no purchases and 2 sales.

The record was last updated on 4 March 2026 with an open-market sale (€26k) in Annexon, Inc. The latest purchase dates back some time: it was published 2,276 days ago, on 28 July 2020. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.